We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Delirium in Acute General Medicine: A Decade-Long Study on Occurrence, Risk Factors, and Long-Term Outcomes

MedXY Editorial Team•Oct 3, 2025•Clinical Updates
deliriumDementiaFrailtyMortality

Highlight

– Delirium affects 23% of acute general medicine patients, increasing with age.
– Major associated factors include dementia, frailty, comorbidity, and pre-admission dependency.
– Delirium significantly predicts longer hospital stays, increased discharge care needs, and mortality, with effects lasting up to 10 years.
– Outcomes are notably worse in patients aged 65-74 years without existing dementia, underscoring priority groups for intervention.

Study Background and Disease Burden

Delirium is an acute neuropsychiatric syndrome characterized by sudden onset of confusion and impaired attention, common among hospitalized patients, particularly older adults. Its occurrence signals vulnerability and often portends worse clinical outcomes including prolonged hospitalization, increased care dependency, and elevated mortality. Despite its clinical significance, reliable long-term data on delirium incidence, risk profiles, and outcomes across broad adult populations in acute medicine remain limited, hampering efforts to optimize care pathways and preventive strategies. This gap is critical given the aging global population and increasing dementia prevalence, conditions that amplify delirium risk.

Study Design

This longitudinal observational study was conducted at the John Radcliffe Hospital in Oxford, UK, encompassing six successive 8-week sampling periods between September 2010 and November 2018. It included 1,846 consecutive adults aged 16 to 102 admitted to the acute general (internal) medicine service. Delirium diagnosis was prospectively assessed with the Confusion Assessment Method and DSM-IV criteria, categorizing cases as either prevalent (within 48 hours of admission) or incident (developing after 48 hours). Data on demographics, dementia and comorbidity status, frailty, illness severity, and functional dependency were collected. Statistical analyses involved adjusted odds ratios (adjORs) for delirium associations with clinical variables and adjusted hazard ratios (adjHRs) for mortality over a 10-year follow-up.

Key Findings

Overall delirium prevalence was 23% (426 patients), with 68% prevalent and 17% incident cases. Notably, delirium occurrence rose markedly with age: 2% in patients under 50, 9% in ages 50–64, 20% in 65–74, 35% in 75–89, and 46% in those 90 or older. Among patients younger than 65 with delirium, 76% had underlying neurological or neuropsychiatric disorders. In patients aged 65 or older, delirium strongly correlated with dementia (adjOR 3.63), pre-admission dependency (adjOR 2.63), comorbidity burden (adjOR 1.04 per unit increase), and frailty (adjOR 3.62 moderate risk; 11.85 high risk, relative to low risk). Correlations were stronger in those without dementia than in those with dementia.

Clinically, delirium predicted hospital stays longer than 7 days (adjOR 2.48), increased discharge care requirements (adjOR 2.41), and higher inpatient mortality (adjOR 2.45). The heightened mortality risk was most pronounced immediately after admission but persisted over 10 years (adjHR 2.03 for 30-day mortality and 1.52 for 10-year mortality). Excess mortality was greater among younger older adults (65–74 years) and in those without dementia compared to patients with dementia.

Expert Commentary

This large-scale, prospective, and longitudinal design affords robust insights into delirium epidemiology in general medicine, capturing both early and incident cases. The study validates current UK and international guidelines advocating delirium screening for all patients aged 65 and older at hospital admission. Particularly striking is the finding that delirium’s adverse outcomes are disproportionately more severe in the 65–74 age group without dementia—underscoring that this cohort may represent a crucial target for focused delirium prevention, detection, and intervention strategies. Differences in delirium associations between patients with and without pre-existing dementia suggest distinct pathophysiological or vulnerability pathways warranting tailored approaches.

Limitations include single-center data which may impact generalizability, and potential confounding by unmeasured variables such as medication use or environmental factors. Nonetheless, the extended 10-year follow-up period significantly strengthens the evidence base on delirium’s long-term impact.

Conclusion

This longitudinal observational study highlights delirium as a common and serious complication in acute general medicine, strongly related to age, frailty, dementia, and comorbidities. The study supports routine on-admission delirium screening beginning at age 65, with an emphasis on the 65-74 age group without dementia where outcomes are most adverse. These findings provide a compelling rationale for prioritizing clinical trials and interventions to mitigate delirium’s impact, ultimately improving hospital resource allocation, patient trajectories, and health policy frameworks.

References

Gan JM, Boucher EL, Lovett NG, Roche S, Smith SC, Pendlebury ST. Occurrence, associated factors, and outcomes of delirium in patients in an adult acute general medicine service in England: a 10-year longitudinal, observational study. Lancet Healthy Longev. 2025 Jul;6(7):100731. doi: 10.1016/j.lanhl.2025.100731. PMID: 40754365; PMCID: PMC12316638.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Frailty as a Predictor of Surgical Outcomes in Cricopharyngeus Muscle Dysfunction: Enhancing Patient Selection and ExpectationsFrailty negatively impacts swallowing improvement after UES surgery for cricopharyngeus muscle dysfunction, with nonfrail patients experiencing greater benefits. Frailty assessment aids preoperative planning without excluding patients fromSep 23, 2026Impact of Age at Type 1 Diabetes Onset on Mortality and Organ Complications: Insights from a Nationwide Swedish CohortYounger age at type 1 diabetes diagnosis significantly increases risks of mortality, cardiovascular, and kidney complications; each additional year delay in onset reduces these risks. This review synthesizes nationwide cohort findings and cSep 23, 2026Pre-ICU Balanced Crystalloids Reduce Mortality in Sepsis: Insights from a Large Multicenter Cohort StudyA large multicenter study shows that balanced crystalloids administered before ICU admission in sepsis patients reduce 30-day mortality compared to saline, supporting early fluid choice’s impact on sepsis outcomes.Sep 23, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Efficacy and Safety of Semaglutide According to Frailty Status: Insights from the SELECT Randomized Clinical Trial Post Hoc Analysis
Semaglutide demonstrates consistent cardiovascular benefits and safety across frailty levels in overweight adults with cardiovascular disease, enhancing quality of life and frailty status without increased adverse events.
Sep 21, 2026
Age, Anthracycline Use, and Mortality Outcomes in Classic Hodgkin Lymphoma: Insights from a Large Complete Population CohortThis review analyzes the impact of age and anthracycline-based chemotherapy on mortality in 28,000 classic Hodgkin lymphoma patients, highlighting poorer outcomes in the elderly and the therapeutic nuances influencing survival.Sep 21, 2026
Impact of Hospital Transfer-In Prevalence on Risk-Adjusted Outcomes: Insights from a National Retrospective Cohort StudyThis review synthesizes evidence on how hospitals’ prevalence of transfer-in patients relates to risk-adjusted mortality, length of stay, and charges, highlighting complex interplay between patient case mix and hospital performance meSep 21, 2026